CHLD
CHANGE OF OWNER RECEIVED FROM IB
25/10/2024
Voltar para busca
Dado oficial do USPTO
MONICA HEALTHCARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
10/01/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10, 44
Data de depósito
15/09/2008
Data de registro
08/06/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/09/2020
Última transação
10/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
US
Examinador
THOMAS, JULIE
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of stylized lettering forming the wording "MONICA" with "HEALTHCARE" appearing below. The stylized image of a pregnant woman replaces the letter "I" in "MONICA" and the letter "L" in "HEALTHCARE".
Titulares e representantes
Titulares
GE Precision Healthcare LLC
Monica Healthcare Limited
Representantes
Marina Dostal GE Precision Healthcare LLC
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Medical software for displaying electrophysiological signals from a pregnant woman; medical software for interpreting electrophysiological signals from a pregnant woman; software being algorithms for interpreting electrophysiological signals from a pregnant woman; medical software for generating data regarding foetal movements by interpreting electrophysiological signals from a pregnant woman; medical software for emulating electrophysiological signals from a pregnant woman; medical software for displaying foetal electrocardiographic signals; medical software for interpreting foetal electrocardiographic signals; software being algorithms for interpreting foetal electrocardiographic signals; medical software for generating data regarding foetal movements by interpreting foetal electrocardiographic signals; medical software for emulating foetal electrocardiographic signals; medical software for displaying foetal and maternal heart rates from a pregnant woman; software for interpreting foetal and maternal heart rates from a pregnant woman; software being algorithms for interpreting foetal and maternal heart rates from a pregnant woman; medical software for displaying electrohysterograms relating to the uterine activity of a pregnant woman; software for interpreting electrohysterograms relating to the uterine activity of a pregnant woman; software being algorithms for interpreting electrohysterograms relating to the uterine activity of a pregnant woman ; software for analysing the morphology of foetal electrocardiographic complexes; software for generating a trigger for foetal heart imaging; software for generating foetal heart images; medical software for use in displaying foetal heart images
Classe 10
Vital sign monitoring apparatus; instruments for use in monitoring vital signs of a foetus; foetal heart monitors; non-implantable instruments for use monitoring the heart of a foetus; non-implantable foetal heart activity recorders; maternal heart monitors; instruments for use monitoring the heart of a pregnant woman; non-implantable maternal heart activity recorders; electronic foetal heart signal monitors; electronic foetal heart monitors; electronic foetal heart signal recorders; electronic maternal heart rate monitors; electronic instruments for use monitoring the heart signal of a pregnant woman; electronic maternal heart signal recorders; medical apparatus for extracting in real time foetal and maternal heart rate; foetal electrocardiographic monitors; foetal electrocardiographic instruments; foetal electrocardiographic recorders; instruments for use in monitoring the uterine activity of a pregnant woman; instruments for use in recording the uterine activity of a pregnant woman; instruments for use in capturing the morphological nature of electrocardiographic complexes on different parts of a pregnant woman's abdomen; instruments for use in recording the morphological nature of electrocardiographic complexes on different parts of a pregnant woman's abdomen; medical electrodes; electrophysiology electrodes for medical use; electrodes for use with foetal monitoring apparatus; consumable electrodes for use with foetal monitoring apparatus; electrodes for use with foetal electrocardiographic monitors; cutaneous electrodes for medical use; devices for securing medical electrodes to the skin of a patientmedical belts; devices for securing cutaneous electrodes to the skin of a patientmedical belts; apparatus for medical image formationmedical ultrasound apparatus; apparatus for foetal image formationmedical ultrasound apparatus; apparatus for foetal heart image formationmedical ultrasound apparatus; electronic devices for emulating electrophysiological signals from a pregnant woman on a computer; electronic devices for emulating foetal electrocardiographic signals on a computer; the aforementioned goods adapted to be portablehand-heldused in both the home and medical establishments and adapted to use wireless telemetry
Classe 44
Interpretation of electrophysiological signals from a pregnant woman; interpretation of foetal electrocardiographic signals; interpretation of the morphology of foetal electrocardiographic complexes; interpretation of the foetal and maternal heart rate from a pregnant woman; interpretation of electrohysterograms relating to the uterine activity of a pregnant woman; interpretation of foetal movement data; interpretation of foetal heart images; medical analysis service relating to electrocardiographic signals; medical analysis service relating to foetal and maternal heart rate from a pregnant woman; medical analysis for diagnosis and treatment of conditions afflicting the foetus; medical analysis service for diagnosis and treatment of conditions afflicting pregnant women; medical analysis service relating to the morphology of foetal electrocardiographic complexes; medical analysis service relating to electrohysterograms; medical analysis service relating to foetal movement data; medical analysis service relating to foetal heart images; health care consultancy services relating to foetal health; health care consultancy services relating to the health of pregnant women; provision of medical information relating to foetal health; provision of medical information relating to the health of pregnant women; provision of medical information relating to foetal electrocardiographic signals; provision of medical information relating to foetal and maternal heart rates; provision of medical information relating to electrohysterograms; provision of medical information relating to the morphology of foetal electrocardiographic complexes; provision of medical information relating to foetal movement; provision of medical information relating to foetal heart images; medical services for the diagnosis of conditions of the human bodymonitoring and reporting services; the aforementioned services provided though the internet; medical advisory and consultancy services relating to all the aforementioned services
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/02/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/06/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/05/2021
INPC
INVALIDATION PROCESSED
06/05/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/05/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/09/2020
71AG
REGISTERED-SEC.71 ACCEPTED
03/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2020
ES71
TEAS SECTION 71 RECEIVED
08/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/06/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
25/10/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
23/02/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/02/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/12/2017
INPC
INVALIDATION PROCESSED
06/12/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
27/11/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
26/05/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
25/03/2017
INPC
INVALIDATION PROCESSED
25/03/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
15/03/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
15/07/2016
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED
15/07/2016
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
15/07/2016
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
15/07/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/07/2016
ES75
TEAS SECTION 71 & 15 RECEIVED
08/06/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/09/2010
FIMP
FINAL DISPOSITION PROCESSED
09/09/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2010
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
30/04/2010
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/04/2010
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/04/2010
PUBO
PUBLISHED FOR OPPOSITION
23/03/2010
NPUB
NOTICE OF PUBLICATION
03/03/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/02/2010
ALIE
ASSIGNED TO LIE
12/02/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/01/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/01/2010
CNRT
NON-FINAL ACTION MAILED
15/07/2009
CNRT
NON-FINAL ACTION WRITTEN
14/07/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/06/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/06/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/06/2009
RFNT
REFUSAL PROCESSED BY IB
13/02/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/12/2008
RFRR
REFUSAL PROCESSED BY MPU
22/12/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/12/2008
CNRT
NON-FINAL ACTION WRITTEN
19/12/2008
DOCK
ASSIGNED TO EXAMINER
16/12/2008
MAFR
APPLICATION FILING RECEIPT MAILED
18/11/2008
NWAP
NEW APPLICATION ENTERED
14/11/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/11/2008
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MONICA HEALTHCARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.